Arizona medical device maker W.L. Gore & Assoc. announced CE Mark approval in the European Union for new components of its Gore Excluder AAA endoprosthesis in treatment of abdominal aortic aneurysms.
European regulators cleared Gore’s lower-profile 31 mm diameter ipsilateral leg and 32 mm aortic extender, designed for use with the Excluder AAA stent-graft in sealing off aneurysms and creating new paths for blood flow.
The Incraft AAA system is under investigation through the company’s multi-center, prospective, non-randomized INNOVATION study in AAA patients, according to a press release.
Medtronic (NYSE:MDT) infringes a pair of patents licensed to Endotach LLC with 3 of its stent grafts for treating abdominal aortic aneurysms, according to a lawsuit filed by Endotach against the medtech titan.
The Frisco, Texas-based company holds the exclusive license to the duo of patents from their inventor’s widow, according to court documents.
Medtronic presented the new data, compiled from a U.S. investigational device exemption study and an international ENGAGE registry of Endurant AAA patients, at the VEITHsymposium in New York this week.
Florida-based stent maker Bolton Medical won FDA clearance for its thoracic-specific stent-graft system, the company announced today.
Bolton’s Relay thoracic stent-graft device and delivery system is designed specifically for minimally invasive treatment of thoracic aortic aneurysms and penetrating atherosclerotic ulcers, and it comes in a range of sizes, according to a press release.